A Phase II, Open-Label, Single-Arm Trial of [Fam]-Trastuzumab Deruxtecan DS-8201a in HER2-Positive, Unresectable and/or Metastatic Gastric or Gastro-Esophageal Junction GEJ Adenocarcinoma Subjects Who Have Progressed On or After A Trastuzumab-Containing Regimen

Brief Summary

Type:
Other

Study Type:
Treatment

Phase:
II

ClinicalTrials.gov Identifier:
NCT04014075

Study #:
STUDY00145601

Start Date:
Jan 01, 0001

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT04014075

View Complete Trial Details & Eligibility at ClinicalTrials.gov